VBI Archives - Rvpg media

VBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Q3 marked a meaningful quarter for partnerships with a recently announced prophylactic hepatitis B commercialization collaboration in certain European countries with Valneva, and a clinical collaboration in glioblastoma with Agenus PreHevbrio™ [Hepatitis B Vaccine (Recombinant)], launched in the U.S. at the end of Q1 2022, is advancing through commercial stage gates required to enable broad … Read more